1. Home
  2. ROG vs TARS Comparison

ROG vs TARS Comparison

Compare ROG & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROG
  • TARS
  • Stock Information
  • Founded
  • ROG 1832
  • TARS 2016
  • Country
  • ROG United States
  • TARS United States
  • Employees
  • ROG N/A
  • TARS N/A
  • Industry
  • ROG Industrial Machinery/Components
  • TARS Medicinal Chemicals and Botanical Products
  • Sector
  • ROG Technology
  • TARS Health Care
  • Exchange
  • ROG Nasdaq
  • TARS Nasdaq
  • Market Cap
  • ROG 1.9B
  • TARS 1.8B
  • IPO Year
  • ROG N/A
  • TARS 2020
  • Fundamental
  • Price
  • ROG $103.59
  • TARS $44.83
  • Analyst Decision
  • ROG
  • TARS Strong Buy
  • Analyst Count
  • ROG 0
  • TARS 5
  • Target Price
  • ROG N/A
  • TARS $54.20
  • AVG Volume (30 Days)
  • ROG 148.4K
  • TARS 1.1M
  • Earning Date
  • ROG 10-24-2024
  • TARS 11-13-2024
  • Dividend Yield
  • ROG N/A
  • TARS N/A
  • EPS Growth
  • ROG N/A
  • TARS N/A
  • EPS
  • ROG 2.67
  • TARS N/A
  • Revenue
  • ROG $842,500,000.00
  • TARS $129,621,000.00
  • Revenue This Year
  • ROG N/A
  • TARS $852.60
  • Revenue Next Year
  • ROG $3.60
  • TARS $74.21
  • P/E Ratio
  • ROG $38.77
  • TARS N/A
  • Revenue Growth
  • ROG N/A
  • TARS 801.96
  • 52 Week Low
  • ROG $96.10
  • TARS $15.60
  • 52 Week High
  • ROG $138.85
  • TARS $52.99
  • Technical
  • Relative Strength Index (RSI)
  • ROG 49.94
  • TARS 57.98
  • Support Level
  • ROG $101.63
  • TARS $46.22
  • Resistance Level
  • ROG $114.05
  • TARS $52.99
  • Average True Range (ATR)
  • ROG 3.17
  • TARS 3.62
  • MACD
  • ROG -0.02
  • TARS -0.33
  • Stochastic Oscillator
  • ROG 36.99
  • TARS 42.09

About ROG Rogers Corporation

Rogers Corporation designs develop and manufacture engineered materials and components for sale to original equipment manufacturers and component suppliers. The firm operates in three business segments: advanced connectivity solutions, which manufactures circuit materials for applications in communications infrastructure, automotive, and consumer electronics markets; elastomeric material solutions, which provide cushioning, sealing, and impact protection in automotive, transportation, and construction applications; and power electronics solutions, which sells ceramic substrate materials for power module applications. The firm generates revenue in the United States, China, and Germany, but has a presence around the world.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Share on Social Networks: